Business
DarioHealth Announces Four New Employer Contracts
New contracts expand Dario's footprint to more than 40 clients in the employer market NEW YORK, Feb. 8, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO),

About this update from Dariohealth Corp.
[{"type":"text","content":"New contracts expand Dario's footprint to more than 40 clients in the employer market\n\n\nNEW YORK, Feb. 8, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced several new contracts to deliver its digital therapeutics solutions for four new employers. The new accounts are expected to launch during the first and second quarters of 2022.\nThe new clients include a northeast regional employer contracted for Dario's diabetes solution and three employers - including two educational organizations and a regional professional services firm - launching with Dario's behavioral health solution. \nDario closed 2021 with a total of 54 new contracts in its first full year of selling digital therapeutics in the business-to-business market. The company now has a range of health plans, providers and employers taking advantage of its digital therapeutics platform designed to address the most common chronic conditions: diabetes, hypertension, weight management, musculoskeletal, and behavioral health. \n\"2022 is off to a strong start as Dario continues to experience quick growth with a total of seven new contracts in January 2022. The employer market increasingly seeks out Dario for our hyper-personalized, integrated multi-condition digital therapeutic platform, and we are excited to see so many new customers launching on the platform over the next several months,\" said Rick Anderson, President and General Manager, North America, DarioHealth.\nAbout DarioHealth Corp.\nDarioHealth Corp. (Nasdaq: DRIO) is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market - covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform.\nDario's next-generation, AI-powered, digital therapeutic platform supports more than just an individual's disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help individuals improve health and sustain meaningful outcomes. \nDario's unique ...